Other News To Note
Wednesday, November 21, 2012
Kancera AB, of Stockholm, Sweden, said results of a collaboration with a research group at the Karolinska Institute showed that the survival of an aggressive type of human cancer cells from pancreatic cancer is ROR-1-dependent.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.